Domestic Guidance on Celecoxib, Naproxen Released

The Korea Food and Drug Administration (KFDA) released its pharmaceutical safety memorandum addressed to the healthcare professionals and to the general public, citing its current effort in reviewing the safety issues for drugs containing the active ingredients of celecoxib and naproxen, and the suggested guidance to the doctors and pharmacists.

Celecoxib is a nonsteroidal anti-inflammatory ...